Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2
- PMID: 20236092
- DOI: 10.1042/BA20090256
Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2
Abstract
The expression of rhIL-2 (recombinant human interleukin-2) in bacteria results in the formation of insoluble inclusion-body aggregates. These aggregates were first solubilized under denaturing conditions (sodium phosphate buffer solution containing 8 M urea and 10 mM 2-mercaptoethanol) and then purified using IMAC (immobilized metal-ion-affinity chromatography). IMAC was used to capture rhIL-2. The protein was gradually refolded on the column by a gradient elution (8 M to 0 M urea) in the presence of 10% (v/v) glycerol. Glycerol was used to prevent protein aggregation during the refolding step. Using this method, rhIL-2 was collected at 97% purity and its activity was measured by the lymphocyte transformation test. The measured activity was identical with commercial human interleukin-2.
Similar articles
-
[Using process of refolding the protein to obtain recombinant human interleukin-1 receptor antagonist].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2007 Oct;24(5):1128-32. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2007. PMID: 18027711 Chinese.
-
Purification and refolding of recombinant human interferon-gamma in urea-ammonium chloride solution.Protein Expr Purif. 2010 Sep;73(1):70-3. doi: 10.1016/j.pep.2010.03.026. Epub 2010 Apr 2. Protein Expr Purif. 2010. PMID: 20363329
-
On-column refolding and purification of recombinant human interleukin-1 receptor antagonist (rHuIL-1ra) expressed as inclusion body in Escherichia coli.Biotechnol Lett. 2005 Aug;27(16):1177-82. doi: 10.1007/s10529-005-8655-5. Biotechnol Lett. 2005. PMID: 16158260
-
Solubilization and refolding of bacterial inclusion body proteins.J Biosci Bioeng. 2005 Apr;99(4):303-10. doi: 10.1263/jbb.99.303. J Biosci Bioeng. 2005. PMID: 16233795 Review.
-
Expression, Solubilization, Refolding and Final Purification of Recombinant Proteins as Expressed in the form of "Classical Inclusion Bodies" in E. coli.Protein Pept Lett. 2021;28(2):122-130. doi: 10.2174/0929866527999200729182831. Protein Pept Lett. 2021. PMID: 32729411 Review.
Cited by
-
Different Stationary Phase Selectivities and Morphologies for Intact Protein Separations.Chromatographia. 2017;80(5):665-687. doi: 10.1007/s10337-016-3168-z. Epub 2016 Sep 23. Chromatographia. 2017. PMID: 28529348 Free PMC article. Review.
-
Expression and functional characterization of an anti-CD22 scFv targeting B-cell malignancies.Res Pharm Sci. 2025 Jun 17;20(3):373-391. doi: 10.4103/RPS.RPS_248_24. eCollection 2025 Jun. Res Pharm Sci. 2025. PMID: 40687289 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources